3, 5-disubstituted pyrid-2-ones useful as inhibitors of Tec family of nonreceptor tyrosine kinases

Details for Australian Patent Application No. 2006284900 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Knegtel, Ronald; Ramaya, Sharn; Jimenez, Juan-Miguel; Durrant, Steven; Charrier, Jean-Damien; Brenchley, Guy; Mortimore, Michael

Agent Cullen & Co

Pub. Number AU-A-2006284900

PCT Pub. Number WO2007/027729

Priority 60/712,460 29.08.05 US

Filing date 28 August 2006

Wipo publication date 8 March 2007

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/444 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/027729 Priority application(s): WO2007/027729

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006284903-Methods for in-situ formation of slots in a soderberg anode

2006284895-Steel compositions, methods of forming the same, and articles formed therefrom